Kei Kunimasa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kei Kunimasa has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Tadashi Ishida
Respiratory Medicine Department, Kurashiki Central Hospital, Kurashiki-Shi, Okayama, Japan
6 shared publicationsMachiko Arita
Department of Respiratory Medicine, Kurashiki Central Hospital, Japan
3 shared publicationsAkihiro Nishiyama
Department of Respiratory Medicine, Kurashiki Central Hospital, Japan
2 shared publicationsGen Masuda
Department of Respiratory Medicine, Kurashiki Central Hospital, Japan
2 shared publicationsMasahiro Iwasaku
Department of Respiratory Medicine, Kurashiki Central Hospital, Japan
2 shared publicationsSatoshi Konishi
Department of Respiratory Medicine, Kurashiki Central Hospital, Japan
2 shared publications
Latest Publications
- Open Access
- 21 May 2012
- Published by Springer Nature in BMC Cancer
- Vol. 12 (1) , 185
Customized chemotherapy based on epidermal growth factor receptormutation status for elderly patients with advanced non-small-cell lung cancer: a phase II trial
Elderly patients are more vulnerable to toxicity from chemotherapy. Activating epidermal growth factor receptor (EGFR) mutations in non-small-cell lung cancer (NSCLC) are associated with enhanced response to EGFR tyrosine-kinase inhibitors. We studied patients with advanced NSCLC for whom treatment was customized based on EGFR mutation status.
- 21 May 2012
- Published by Springer Nature in BMC Cancer
- Vol. 12 (1) , 185
Open AccessCustomized chemotherapy based on epidermal growth factor receptormutation status for elderly patients with advanced non-small-cell lung cancer: a phase II trial
Elderly patients are more vulnerable to toxicity from chemotherapy. Activating epidermal growth factor receptor (EGFR) mutations in non-small-cell lung cancer (NSCLC) are associated with enhanced response to EGFR tyrosine-kinase inhibitors. We studied patients with advanced NSCLC for whom treatment was customized based on EGFR mutation status.
- Open Access
- 21 February 2012
- Published by BMJ in BMJ Case Reports
- Vol. 2012
Reversible lesion in the splenium of the corpus callosum associated with Legionnaires’ pneumonia
- 21 February 2012
- Published by BMJ in BMJ Case Reports
- Vol. 2012
Open AccessReversible lesion in the splenium of the corpus callosum associated with Legionnaires’ pneumonia
- Open Access
- 1 January 2012
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 51 (4) , 431-434
Successful Treatment of Non-small Cell Lung Cancer with Gefitinib after Severe Erlotinib-related Hepatotoxicity
Gefitinib and erlotinib are first-generation small molecular inhibitors of EGFR tyrosine kinase activity. To the best of our knowledge, to date, two reports have stated that patients with NSCLC who develop severe hepatotoxicity secondary to gefitinib treatment can be safely switched to erlotinib. However, the reverse situation has not been reported. Here, we present the first case with non-small cell lung cancer harboring EGFR mutation who developed grade 3/4 hepatotoxicity after initiation of erlotinib, which resolved when therapy was changed to gefitinib. As far as we know, this is the first report showing the efficacy of gefitinib for a non-small cell lung cancer patient who developed severe hepatotoxicity while under erlotinib therapy.
- 1 January 2012
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 51 (4) , 431-434
Open AccessSuccessful Treatment of Non-small Cell Lung Cancer with Gefitinib after Severe Erlotinib-related Hepatotoxicity
Gefitinib and erlotinib are first-generation small molecular inhibitors of EGFR tyrosine kinase activity. To the best of our knowledge, to date, two reports have stated that patients with NSCLC who develop severe hepatotoxicity secondary to gefitinib treatment can be safely switched to erlotinib. However, the reverse situation has not been reported. Here, we present the first case with non-small cell lung cancer harboring EGFR mutation who developed grade 3/4 hepatotoxicity after initiation of erlotinib, which resolved when therapy was changed to gefitinib. As far as we know, this is the first report showing the efficacy of gefitinib for a non-small cell lung cancer patient who developed severe hepatotoxicity while under erlotinib therapy.
- Open Access
- 1 January 2012
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 51 (6) , 685-686
Diffuse Metastases of Lung Adenocarcinoma with EGFR mutation
- 1 January 2012
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 51 (6) , 685-686
Open AccessDiffuse Metastases of Lung Adenocarcinoma with EGFR mutation
- Open Access
- 1 January 2012
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 51 (9) , 1081-1085
Drug-induced Interstitial Pneumonitis due to Low-dose Lenalidomide
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies
- 1 January 2012
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 51 (9) , 1081-1085
Open AccessDrug-induced Interstitial Pneumonitis due to Low-dose Lenalidomide
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies
- Open Access
Pulmonary cystic lesion in a trauma patient
In the emergency room, he appeared uncomfortable. His blood pressure was 145/110 mm Hg, pulse was 112 beats per minute and temperature was 36.7°C; his respiratory rate was 34 breaths per minute and oxygen saturation was 85% while breathing ambient air. No jugular venous distention or bruits in the neck were noted. Examination of the heart revealed a rapid rhythm. Respiratory sounds were diminished bilaterally with a prolonged expiratory phase. Drawing up his knees resulted in increased back pain. No abnormal sensations such as numbness, tingling or pain were observed in the lower extremities and no problems were identified in joint motions of the lower extremities. No other abnormalities were noted in the remainder of the physical examination. Posteroanterior chest radiography in a supine position showed a consolidation and cavity in the left lung, which had not been evident on a previous film (figure 1). After a brief interval, the level of consciousness deteriorated, and both blood pressure and oxygen saturation suddenly decreased. Contrast-enhanced CT was performed for suspected traumatic haemorrhagic shock.
Open AccessPulmonary cystic lesion in a trauma patient
In the emergency room, he appeared uncomfortable. His blood pressure was 145/110 mm Hg, pulse was 112 beats per minute and temperature was 36.7°C; his respiratory rate was 34 breaths per minute and oxygen saturation was 85% while breathing ambient air. No jugular venous distention or bruits in the neck were noted. Examination of the heart revealed a rapid rhythm. Respiratory sounds were diminished bilaterally with a prolonged expiratory phase. Drawing up his knees resulted in increased back pain. No abnormal sensations such as numbness, tingling or pain were observed in the lower extremities and no problems were identified in joint motions of the lower extremities. No other abnormalities were noted in the remainder of the physical examination. Posteroanterior chest radiography in a supine position showed a consolidation and cavity in the left lung, which had not been evident on a previous film (figure 1). After a brief interval, the level of consciousness deteriorated, and both blood pressure and oxygen saturation suddenly decreased. Contrast-enhanced CT was performed for suspected traumatic haemorrhagic shock.
- Open Access
- 1 January 2011
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 50 (18) , 2035-2038
Chemical Pneumonitis and Acute Lung Injury Caused by Inhalation of Nickel Fumes
A 50-year-old man with a 30-year occupational history of welding presented with low-grade fever, fatigue and persistent dry cough. Computed tomography (CT) of the chest revealed interlobular septal thickening and bilateral non-segmental patchy ground-glass opacities except in the sub-pleural zone. He revealed that he had inhaled nickel fumes 3 days previously at work. These findings suggested a diagnosis of pneumonitis induced by inhalation of nickel fumes. Fewer reports describe pneumonitis associated with the inhalation of nickel compared with zinc fumes. Although nickel compounds are particularly pernicious among the transition metals and more toxic than zinc compounds, nickel fume inhalation rarely induces lethal acute respiratory distress syndrome. Our patient was successfully treated with corticosteroid.
- 1 January 2011
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 50 (18) , 2035-2038
Open AccessChemical Pneumonitis and Acute Lung Injury Caused by Inhalation of Nickel Fumes
A 50-year-old man with a 30-year occupational history of welding presented with low-grade fever, fatigue and persistent dry cough. Computed tomography (CT) of the chest revealed interlobular septal thickening and bilateral non-segmental patchy ground-glass opacities except in the sub-pleural zone. He revealed that he had inhaled nickel fumes 3 days previously at work. These findings suggested a diagnosis of pneumonitis induced by inhalation of nickel fumes. Fewer reports describe pneumonitis associated with the inhalation of nickel compared with zinc fumes. Although nickel compounds are particularly pernicious among the transition metals and more toxic than zinc compounds, nickel fume inhalation rarely induces lethal acute respiratory distress syndrome. Our patient was successfully treated with corticosteroid.
- Open Access
- 1 January 2011
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 50 (20) , 2417-2421
Peripheral T-cell Lymphoma not Otherwise Specified (PTCL-NOS) in a Patient with Hypereosinophilic Syndrome Showing Multiple Nodules on Chest Computed Tomography
Hypereosinophilic syndrome (HES) encompasses both myeloproliferative and lymphoproliferative diseases. We encountered a rare case of lymphocytic HES followed by malignant T cell lymphoma, who was diagnosed as eosinophilic pneumonia upon the first visit. During the clinical course, the transition of the chest CT findings from bilateral multifocal ground-glass opacities and consolidations to bilateral scattered multiple small nodules was impressive and suggestive. Given the increased risk of developing T-cell lymphoma, patients with HES (especially lymphocytic-HES) should be monitored on a regular basis to detect this complication as early as possible.
- 1 January 2011
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 50 (20) , 2417-2421
Open AccessPeripheral T-cell Lymphoma not Otherwise Specified (PTCL-NOS) in a Patient with Hypereosinophilic Syndrome Showing Multiple Nodules on Chest Computed Tomography
Hypereosinophilic syndrome (HES) encompasses both myeloproliferative and lymphoproliferative diseases. We encountered a rare case of lymphocytic HES followed by malignant T cell lymphoma, who was diagnosed as eosinophilic pneumonia upon the first visit. During the clinical course, the transition of the chest CT findings from bilateral multifocal ground-glass opacities and consolidations to bilateral scattered multiple small nodules was impressive and suggestive. Given the increased risk of developing T-cell lymphoma, patients with HES (especially lymphocytic-HES) should be monitored on a regular basis to detect this complication as early as possible.
- 1 January 2011
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 50 (22) , 2865
Thoracic Sandwich Sign
- 1 January 2011
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 50 (22) , 2865
Thoracic Sandwich Sign